302-49-8

Usage

Uses

Used in Insect Control:
Uredepa is used as an insect chemosterilant for controlling insect populations. It disrupts the reproductive system of insects, leading to a reduction in their numbers.
Used in Antiparasitic Applications:
Uredepa is used as an antiparasitic agent for treating parasitic infections. Its chemosterilant properties help in controlling the growth and reproduction of parasites, thereby reducing their impact on the host.

InChI:InChI=1/C7H14N3O3P/c1-2-13-7(11)8-14(12,9-3-4-9)10-5-6-10/h2-6H2,1H3,(H,8,11,12)

Upstream product

• 870-30-4 isocyanatophosphonic dichloride 
• 151-56-4 ethyleneimine 
• 64-17-5 ethanol 

Downstream Products

• 1980-45-6 benzodepa 
• 103981-99-3 N,N:N',N'-bis(1,2-ethanediyl)-N-<<(2,2,5,5-tetramethyl-1-oxypyrrolidin-3-yl)amino>carbonyl>phosphoric triamide 
• 103981-95-9 N,N:N',N'-bis(1,2-ethanediyl)-N-{[(2,2,5,5-tetramethyl-1-hydroxypyrrolidin-3-yl)amino]carbonyl}phosphoric triamide 

Relevant academic research and scientific papers

Particles with improved solubilization capacity

A particle is disclosed that comprises a first volume of hydrophobe-rich material with tunable dissolution and solubilization characteristics and a distinct second volume of nanostructured nonlamellar liquid crystalline material, said second volume containing said first domain and being capable of being in equilibrium with said first volume. Preferably, the nanostructured nonlamellar liquid crystalline material is capable of being in equilibrium with a polar solvent or a water-immiscible solvent or both.

Solvent systems for pharmaceutical agents

The invention provides compositions, solvent systems, and methods for solubilizing compounds which are otherwise difficult to solubilize. The invention involves the use of a structured fluid (e.g. a liquid crystalline phase, an L1 phase, an L2 phase, an L3 phase, an emulsion, or a microemulsion), comprising a polar solvent, a lipid or a surfactant, and an essential oil or a dissolution/solubilization agent.